Showing results (111-120 of 130) with videos related to

Sort By:
Pageof 13
EJNMMI Research|February 29, 2016
Discovery and characterization of a high-affinity and high-specificity peptide ligand LXY30 for in vivo targeting of α3 integrin-expressing human tumorsWenwu Xiao, Tianhong Li, Fernanda C Bononi, et al.
Aging|October 29, 2021
Serum amylase elevation is associated with adverse clinical outcomes in patients with coronavirus disease 2019Ganxun Li, Tongtong Liu, Guannan Jin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 9, 2013
Histology-related associations of ERCC1, RRM1, and TS biomarkers in patients with non-small-cell lung cancer: implications for therapyMartin K H Maus, Philip C Mack, Stephanie H Astrow, et al.
Biomaterials|August 2, 2016
Novel theranostic nanoporphyrins for photodynamic diagnosis and trimodal therapy for bladder cancerTzu-Yin Lin, Yuanpei Li, Qiangqiang Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 6, 2015
Phase I Trial of Arginine Deprivation Therapy with ADI-PEG 20 Plus Docetaxel in Patients with Advanced Malignant Solid TumorsBenjamin K Tomlinson, James A Thomson, John S Bomalaski, et al.
Frontiers in Oncology|March 28, 2019
Phase II Trial of Cabozantinib Plus Erlotinib in Patients With Advanced Epidermal Growth Factor Receptor (EGFR)-Mutant Non-small Cell Lung Cancer With Progressive Disease on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy: A California Cancer Consortium Phase II Trial (NCI 9303)Karen L Reckamp, Paul H Frankel, Nora Ruel, et al.
Clinical Lung Cancer|December 7, 2016
Randomized Phase 2 Trial of Pharmacodynamic Separation of Pemetrexed and Intercalated Erlotinib Versus Pemetrexed Alone for Advanced Nonsquamous, Non-small-cell Lung CancerTianhong Li, Bilal Piperdi, William V Walsh, et al.
Cancer Chemotherapy and Pharmacology|July 30, 2022
A phase I dose escalation, dose expansion and pharmacokinetic trial of gemcitabine and alisertib in advanced solid tumors and pancreatic cancerJustin A Chen, Jasmine C Huynh, Chun-Yi Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2009
Phase II trial of tipifarnib plus neoadjuvant doxorubicin-cyclophosphamide in patients with clinical stage IIB-IIIC breast cancerJoseph A Sparano, Stacy Moulder, Aslamuzzaman Kazi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 28, 2018
Hybrid Capture-Based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Non-Small Cell Lung CancerAlexa B Schrock, Allison Welsh, Jon H Chung, et al.
Pageof 13